Home  >  Product Launches
Product Launches
+ Font Resize -

Lupin launches generic Wellbutrin XL tablets in US

Our Bureau, Mumbai
Thursday, June 15, 2017, 15:15 Hrs  [IST]

Lupin, the second largest pharma companies in India with net sales of Rs. 17,100 crore plus, has launched its bupropion hydrochloride extended release tablets USP (XL), 150 mg and 300 mg having received an approval from the the US FDA.

Lupin's this tablet is the AB rated generic equivalent of Valeant Pharmaceuticals North America, LLC's Wellbutrin XL tablets, 150 mg and 300 mg. It is indicated for the treatment of major depressive disorder (MDD) and prevention of seasonal affective disorder (SAD) in adults.

Wellbutrin XL tablets had US sales of US$ 758 million.

 

Post Your commentsPOST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
CPhI-WW-Banners-150X60-120618-anim-v2
pharmalytica_150x60_2018
CPhI_MEA_Banner_150x60_2018
150X60px_biowavers
IPE_2018_Banner_150X60
GPRS_150x60_2018
cphikorea_150x60_saffron media
Chemspec_India-2018
CPhI_China_150x60-2018
PharmaTech_Expo_2018
VF118_Banner_150x60_E_D2
IPJPI18_150x60en_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |